Примери за използване на Bone marrow transplantation на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Bone marrow transplantation(for the prevention of graft rejection
It is used in bone marrow transplantation, when you are given bone narrow cells from another person.
Patients treated with myeloablative therapy followed by bone marrow transplantation The recommended starting dose of filgrastim is 1.0 MU/ kg/ day(10 μ g/ kg/ day).
including after bone marrow transplantation.
Mini transplantation is a version of our hematologic oncology and bone marrow transplantation program, founded in 2010.
Knowing that her life is worth 250 000 EUR to perform the life-saving operation of bone marrow transplantation abroad.
fatalities in patients receiving G-CSF after allogeneic bone marrow transplantation(see section 4.8 and 5.1).
In addition, as bone marrow transplantation is frequently used to treat cancer,
The duration of fever was not reduced in patients undergoing myeloablative therapy followed by bone marrow transplantation.
Another well-established use of the concentrate for solution for infusion is the initial treatment of patients undergoing bone marrow transplantation.
Newly diagnosed CML for whom bone marrow transplantation is not considered as the first line of treatment;
the sole wide used stem cell-based medical aid is bone marrow transplantation.
some people with this disorder require bone marrow transplantation.
radiotherapy for malignant disease or bone marrow transplantation.
Additionally, as bone marrow transplantation is frequently used to cure cancer,
the only widely used stem cell-based therapy is bone marrow transplantation.
they are offered to perform bone marrow transplantation.
TRM following treatment with G-CSF after bone marrow transplantation.
On the day when this preparatory phase which takes an average of 7-8 days period ends, bone marrow transplantation is accomplished by transferring new stem cells to the patient.
The duration of fever was not reduced in patients undergoing myeloablative therapy followed by bone marrow transplantation.